CLINICAL_TRIALS
trial_result
· 2015-11-03
Clinical Trial Update: A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age [Phase 1]
Summary
Phase 1 single-dose pharmacokinetic study of Lorcaserin hydrochloride in obese children aged 6 to 11 was completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Obesity | Phase 1 | Status: COMPLETED